Ramelteon used to treat insomnia can reduce the occurrence of osteoporosis
Aim: Melatonin promoted osteoblast differentiation and causes an increase in levels of markers of bone differentiation and proliferation. Ramelteon (RAMEL) activates melatonin receptors and binds to these receptors as non-selective. In this study, we investigated the preventive effects of the melato...
Saved in:
| Main Authors: | Duygu Köse, Zekai Halıcı, Muhammed Yayla, Muhammed Ali Gürbüz, Adem Maman, Ahmet Köse |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Alanya Alaaddin Keykubat University
2021-08-01
|
| Series: | Acta Medica Alanya |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/1775561 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ramelteon exposure and survival of critically Ill sepsis patients: a retrospective study from MIMIC-IV
by: Yun-Yang Han, et al.
Published: (2024-12-01) -
UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer Treatment
by: Richard E. Kast
Published: (2025-03-01) -
Osteoporosis and Fragilty Fractures: An Overview.
by: Ahmet Aslan
Published: (2022-03-01) -
Evaluation of Inflammation in Pathogenesis of Osteoporosis with Neutrophil Lymphocyte and Platelet-Lymphocyte Ratios
by: İsmail Boyraz, et al.
Published: (2015-12-01) -
Safety profile of ramelteon from the perspective of physicians and pharmacists: a 20-year real-world pharmacovigilance analysis based on the FAERS database
by: Jianhong Wu, et al.
Published: (2025-07-01)